ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Enuresis Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-37T12122
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drugs for Enuresis Market Research Report 2022
BUY CHAPTERS

Global Drugs for Enuresis Market Research Report 2025

Code: QYRE-Auto-37T12122
Report
January 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Ferring Pharmaceuticals, Inc.
Pfizer Inc
Mallinckrodt plc
Bayer Corp
Janssen Pharmaceuticals, Inc.
Astellas pharma US Inc.
Urovant Sciences, Inc.

Drugs for Enuresis Market

The global market for Drugs for Enuresis was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The drugs used to treat enuresis are mainly stimulants of central nervous system or antidiuretic hormones
North American market for Drugs for Enuresis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Drugs for Enuresis is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Drugs for Enuresis include Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drugs for Enuresis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Enuresis.
The Drugs for Enuresis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drugs for Enuresis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Enuresis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Drugs for Enuresis Market Report

Report Metric Details
Report Name Drugs for Enuresis Market
Segment by Type
Segment by Application
  • Hospital
  • Specialist Clinic
  • Othere
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Drugs for Enuresis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Drugs for Enuresis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Drugs for Enuresis Market report?

Ans: The main players in the Drugs for Enuresis Market are Allergan, Ferring Pharmaceuticals, Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Urovant Sciences, Inc., Astellas Pharma US, Inc., Bayer Corp, Mallinckrodt, Inc.

What are the Application segmentation covered in the Drugs for Enuresis Market report?

Ans: The Applications covered in the Drugs for Enuresis Market report are Hospital, Specialist Clinic, Othere

What are the Type segmentation covered in the Drugs for Enuresis Market report?

Ans: The Types covered in the Drugs for Enuresis Market report are Anticholinergic Drugs, Tricyclic Antidepressants, Desmopressin

Recommended Reports

Urinary Disorders

Sexual & Reproductive Drugs

Genitourinary Treatments

1 Drugs for Enuresis Market Overview
1.1 Product Definition
1.2 Drugs for Enuresis by Type
1.2.1 Global Drugs for Enuresis Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anticholinergic Drugs
1.2.3 Tricyclic Antidepressants
1.2.4 Desmopressin
1.3 Drugs for Enuresis by Application
1.3.1 Global Drugs for Enuresis Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Othere
1.4 Global Drugs for Enuresis Market Size Estimates and Forecasts
1.4.1 Global Drugs for Enuresis Revenue 2020-2031
1.4.2 Global Drugs for Enuresis Sales 2020-2031
1.4.3 Global Drugs for Enuresis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Drugs for Enuresis Market Competition by Manufacturers
2.1 Global Drugs for Enuresis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Drugs for Enuresis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Drugs for Enuresis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Drugs for Enuresis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drugs for Enuresis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drugs for Enuresis, Product Type & Application
2.7 Global Key Manufacturers of Drugs for Enuresis, Date of Enter into This Industry
2.8 Global Drugs for Enuresis Market Competitive Situation and Trends
2.8.1 Global Drugs for Enuresis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Drugs for Enuresis Players Market Share by Revenue
2.8.3 Global Drugs for Enuresis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs for Enuresis Market Scenario by Region
3.1 Global Drugs for Enuresis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Drugs for Enuresis Sales by Region: 2020-2031
3.2.1 Global Drugs for Enuresis Sales by Region: 2020-2025
3.2.2 Global Drugs for Enuresis Sales by Region: 2026-2031
3.3 Global Drugs for Enuresis Revenue by Region: 2020-2031
3.3.1 Global Drugs for Enuresis Revenue by Region: 2020-2025
3.3.2 Global Drugs for Enuresis Revenue by Region: 2026-2031
3.4 North America Drugs for Enuresis Market Facts & Figures by Country
3.4.1 North America Drugs for Enuresis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Drugs for Enuresis Sales by Country (2020-2031)
3.4.3 North America Drugs for Enuresis Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drugs for Enuresis Market Facts & Figures by Country
3.5.1 Europe Drugs for Enuresis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Drugs for Enuresis Sales by Country (2020-2031)
3.5.3 Europe Drugs for Enuresis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for Enuresis Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs for Enuresis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Drugs for Enuresis Sales by Region (2020-2031)
3.6.3 Asia Pacific Drugs for Enuresis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drugs for Enuresis Market Facts & Figures by Country
3.7.1 Latin America Drugs for Enuresis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Drugs for Enuresis Sales by Country (2020-2031)
3.7.3 Latin America Drugs for Enuresis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for Enuresis Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for Enuresis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Drugs for Enuresis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Drugs for Enuresis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drugs for Enuresis Sales by Type (2020-2031)
4.1.1 Global Drugs for Enuresis Sales by Type (2020-2025)
4.1.2 Global Drugs for Enuresis Sales by Type (2026-2031)
4.1.3 Global Drugs for Enuresis Sales Market Share by Type (2020-2031)
4.2 Global Drugs for Enuresis Revenue by Type (2020-2031)
4.2.1 Global Drugs for Enuresis Revenue by Type (2020-2025)
4.2.2 Global Drugs for Enuresis Revenue by Type (2026-2031)
4.2.3 Global Drugs for Enuresis Revenue Market Share by Type (2020-2031)
4.3 Global Drugs for Enuresis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Drugs for Enuresis Sales by Application (2020-2031)
5.1.1 Global Drugs for Enuresis Sales by Application (2020-2025)
5.1.2 Global Drugs for Enuresis Sales by Application (2026-2031)
5.1.3 Global Drugs for Enuresis Sales Market Share by Application (2020-2031)
5.2 Global Drugs for Enuresis Revenue by Application (2020-2031)
5.2.1 Global Drugs for Enuresis Revenue by Application (2020-2025)
5.2.2 Global Drugs for Enuresis Revenue by Application (2026-2031)
5.2.3 Global Drugs for Enuresis Revenue Market Share by Application (2020-2031)
5.3 Global Drugs for Enuresis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Company Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan Drugs for Enuresis Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Ferring Pharmaceuticals, Inc.
6.2.1 Ferring Pharmaceuticals, Inc. Company Information
6.2.2 Ferring Pharmaceuticals, Inc. Description and Business Overview
6.2.3 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ferring Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolio
6.2.5 Ferring Pharmaceuticals, Inc. Recent Developments/Updates
6.3 Pfizer Inc.
6.3.1 Pfizer Inc. Company Information
6.3.2 Pfizer Inc. Description and Business Overview
6.3.3 Pfizer Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Inc. Drugs for Enuresis Product Portfolio
6.3.5 Pfizer Inc. Recent Developments/Updates
6.4 Janssen Pharmaceuticals, Inc.
6.4.1 Janssen Pharmaceuticals, Inc. Company Information
6.4.2 Janssen Pharmaceuticals, Inc. Description and Business Overview
6.4.3 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Janssen Pharmaceuticals, Inc. Drugs for Enuresis Product Portfolio
6.4.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
6.5 Urovant Sciences, Inc.
6.5.1 Urovant Sciences, Inc. Company Information
6.5.2 Urovant Sciences, Inc. Description and Business Overview
6.5.3 Urovant Sciences, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Urovant Sciences, Inc. Drugs for Enuresis Product Portfolio
6.5.5 Urovant Sciences, Inc. Recent Developments/Updates
6.6 Astellas Pharma US, Inc.
6.6.1 Astellas Pharma US, Inc. Company Information
6.6.2 Astellas Pharma US, Inc. Description and Business Overview
6.6.3 Astellas Pharma US, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Astellas Pharma US, Inc. Drugs for Enuresis Product Portfolio
6.6.5 Astellas Pharma US, Inc. Recent Developments/Updates
6.7 Bayer Corp
6.7.1 Bayer Corp Company Information
6.7.2 Bayer Corp Description and Business Overview
6.7.3 Bayer Corp Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bayer Corp Drugs for Enuresis Product Portfolio
6.7.5 Bayer Corp Recent Developments/Updates
6.8 Mallinckrodt, Inc.
6.8.1 Mallinckrodt, Inc. Company Information
6.8.2 Mallinckrodt, Inc. Description and Business Overview
6.8.3 Mallinckrodt, Inc. Drugs for Enuresis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mallinckrodt, Inc. Drugs for Enuresis Product Portfolio
6.8.5 Mallinckrodt, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for Enuresis Industry Chain Analysis
7.2 Drugs for Enuresis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for Enuresis Production Mode & Process Analysis
7.4 Drugs for Enuresis Sales and Marketing
7.4.1 Drugs for Enuresis Sales Channels
7.4.2 Drugs for Enuresis Distributors
7.5 Drugs for Enuresis Customer Analysis
8 Drugs for Enuresis Market Dynamics
8.1 Drugs for Enuresis Industry Trends
8.2 Drugs for Enuresis Market Drivers
8.3 Drugs for Enuresis Market Challenges
8.4 Drugs for Enuresis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Allergan plc
Ferring Pharmaceuticals, Inc.
Pfizer Inc
Mallinckrodt plc
Bayer Corp
Janssen Pharmaceuticals, Inc.
Astellas pharma US Inc.
Urovant Sciences, Inc.
List of Tables
 Table 1. Global Drugs for Enuresis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Drugs for Enuresis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Drugs for Enuresis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Drugs for Enuresis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Drugs for Enuresis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Drugs for Enuresis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Drugs for Enuresis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Drugs for Enuresis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Drugs for Enuresis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Drugs for Enuresis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Drugs for Enuresis, Product Type & Application
 Table 12. Global Key Manufacturers of Drugs for Enuresis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drugs for Enuresis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Enuresis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drugs for Enuresis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Drugs for Enuresis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Drugs for Enuresis Sales Market Share by Region (2020-2025)
 Table 19. Global Drugs for Enuresis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Drugs for Enuresis Sales Market Share by Region (2026-2031)
 Table 21. Global Drugs for Enuresis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Drugs for Enuresis Revenue Market Share by Region (2020-2025)
 Table 23. Global Drugs for Enuresis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Drugs for Enuresis Revenue Market Share by Region (2026-2031)
 Table 25. North America Drugs for Enuresis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Drugs for Enuresis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Drugs for Enuresis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Drugs for Enuresis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Drugs for Enuresis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Drugs for Enuresis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Drugs for Enuresis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Drugs for Enuresis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Drugs for Enuresis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Drugs for Enuresis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Drugs for Enuresis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Drugs for Enuresis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Drugs for Enuresis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Drugs for Enuresis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Drugs for Enuresis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Drugs for Enuresis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Drugs for Enuresis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Drugs for Enuresis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Drugs for Enuresis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Drugs for Enuresis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Drugs for Enuresis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Drugs for Enuresis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Drugs for Enuresis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Drugs for Enuresis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Drugs for Enuresis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Drugs for Enuresis Sales (K Units) by Type (2020-2025)
 Table 51. Global Drugs for Enuresis Sales (K Units) by Type (2026-2031)
 Table 52. Global Drugs for Enuresis Sales Market Share by Type (2020-2025)
 Table 53. Global Drugs for Enuresis Sales Market Share by Type (2026-2031)
 Table 54. Global Drugs for Enuresis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Drugs for Enuresis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Drugs for Enuresis Revenue Market Share by Type (2020-2025)
 Table 57. Global Drugs for Enuresis Revenue Market Share by Type (2026-2031)
 Table 58. Global Drugs for Enuresis Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Drugs for Enuresis Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Drugs for Enuresis Sales (K Units) by Application (2020-2025)
 Table 61. Global Drugs for Enuresis Sales (K Units) by Application (2026-2031)
 Table 62. Global Drugs for Enuresis Sales Market Share by Application (2020-2025)
 Table 63. Global Drugs for Enuresis Sales Market Share by Application (2026-2031)
 Table 64. Global Drugs for Enuresis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Drugs for Enuresis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Drugs for Enuresis Revenue Market Share by Application (2020-2025)
 Table 67. Global Drugs for Enuresis Revenue Market Share by Application (2026-2031)
 Table 68. Global Drugs for Enuresis Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Drugs for Enuresis Price (US$/Unit) by Application (2026-2031)
 Table 70. Allergan Company Information
 Table 71. Allergan Description and Business Overview
 Table 72. Allergan Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Allergan Drugs for Enuresis Product
 Table 74. Allergan Recent Developments/Updates
 Table 75. Ferring Pharmaceuticals, Inc. Company Information
 Table 76. Ferring Pharmaceuticals, Inc. Description and Business Overview
 Table 77. Ferring Pharmaceuticals, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ferring Pharmaceuticals, Inc. Drugs for Enuresis Product
 Table 79. Ferring Pharmaceuticals, Inc. Recent Developments/Updates
 Table 80. Pfizer Inc. Company Information
 Table 81. Pfizer Inc. Description and Business Overview
 Table 82. Pfizer Inc. Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Inc. Drugs for Enuresis Product
 Table 84. Pfizer Inc. Recent Developments/Updates
 Table 85. Janssen Pharmaceuticals, Inc. Company Information
 Table 86. Janssen Pharmaceuticals, Inc. Description and Business Overview
 Table 87. Janssen Pharmaceuticals, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Janssen Pharmaceuticals, Inc. Drugs for Enuresis Product
 Table 89. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
 Table 90. Urovant Sciences, Inc. Company Information
 Table 91. Urovant Sciences, Inc. Description and Business Overview
 Table 92. Urovant Sciences, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Urovant Sciences, Inc. Drugs for Enuresis Product
 Table 94. Urovant Sciences, Inc. Recent Developments/Updates
 Table 95. Astellas Pharma US, Inc. Company Information
 Table 96. Astellas Pharma US, Inc. Description and Business Overview
 Table 97. Astellas Pharma US, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Astellas Pharma US, Inc. Drugs for Enuresis Product
 Table 99. Astellas Pharma US, Inc. Recent Developments/Updates
 Table 100. Bayer Corp Company Information
 Table 101. Bayer Corp Description and Business Overview
 Table 102. Bayer Corp Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bayer Corp Drugs for Enuresis Product
 Table 104. Bayer Corp Recent Developments/Updates
 Table 105. Mallinckrodt, Inc. Company Information
 Table 106. Mallinckrodt, Inc. Description and Business Overview
 Table 107. Mallinckrodt, Inc. Drugs for Enuresis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Mallinckrodt, Inc. Drugs for Enuresis Product
 Table 109. Mallinckrodt, Inc. Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Drugs for Enuresis Distributors List
 Table 113. Drugs for Enuresis Customers List
 Table 114. Drugs for Enuresis Market Trends
 Table 115. Drugs for Enuresis Market Drivers
 Table 116. Drugs for Enuresis Market Challenges
 Table 117. Drugs for Enuresis Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drugs for Enuresis
 Figure 2. Global Drugs for Enuresis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drugs for Enuresis Market Share by Type: 2024 & 2031
 Figure 4. Anticholinergic Drugs Product Picture
 Figure 5. Tricyclic Antidepressants Product Picture
 Figure 6. Desmopressin Product Picture
 Figure 7. Global Drugs for Enuresis Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Drugs for Enuresis Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Specialist Clinic
 Figure 11. Othere
 Figure 12. Global Drugs for Enuresis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Drugs for Enuresis Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Drugs for Enuresis Sales (2020-2031) & (K Units)
 Figure 15. Global Drugs for Enuresis Average Price (US$/Unit) & (2020-2031)
 Figure 16. Drugs for Enuresis Report Years Considered
 Figure 17. Drugs for Enuresis Sales Share by Manufacturers in 2024
 Figure 18. Global Drugs for Enuresis Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Drugs for Enuresis Players: Market Share by Revenue in Drugs for Enuresis in 2024
 Figure 20. Drugs for Enuresis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Drugs for Enuresis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Drugs for Enuresis Sales Market Share by Country (2020-2031)
 Figure 23. North America Drugs for Enuresis Revenue Market Share by Country (2020-2031)
 Figure 24. United States Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Drugs for Enuresis Sales Market Share by Country (2020-2031)
 Figure 27. Europe Drugs for Enuresis Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Drugs for Enuresis Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Drugs for Enuresis Revenue Market Share by Region (2020-2031)
 Figure 35. China Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Drugs for Enuresis Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Drugs for Enuresis Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Drugs for Enuresis Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Drugs for Enuresis Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Drugs for Enuresis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Drugs for Enuresis by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Drugs for Enuresis by Type (2020-2031)
 Figure 56. Global Drugs for Enuresis Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Drugs for Enuresis by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Drugs for Enuresis by Application (2020-2031)
 Figure 59. Global Drugs for Enuresis Price (US$/Unit) by Application (2020-2031)
 Figure 60. Drugs for Enuresis Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Enuresis Treatment Drugs Market Research Report 2024
Global Constipation Treatment Drug Market Research Report 2025
Global Urinary Incontinence Drug Market Research Report 2025
Global Urinary Products Market Research Report 2025
Urinary Incontinence Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bladder Control Products for Urinary Incontinence Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidiuretic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Incontinence Care Product Market Research Report 2024
Global Incontinence Protection Market Research Report 2025
Global Drugs for Sexual Dysfunction Market Research Report 2024
Global Female Urinary Incontinence Products Market Research Report 2024
Global Chronic Constipation Treatment Drugs Market Research Report 2024
Global Female Urinary Incontinence Treatment Market Research Report 2024
Global Urinary Control System Market Research Report 2024
Global Incontinence Devices and Ostomy Market Research Report 2025
Global Children s Incontinence Products Market Insights Forecast to 2030
Global Severe Incontinence Products Market Research Report 2024
Incontinence Treatment System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hydration Bladder Market Research Report 2024
Global Urology Drugs Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions